WUXILIAB Trademark

Trademark Overview


On Thursday, May 11, 2023, a trademark application was filed for WUXILIAB with the United States Patent and Trademark Office. The USPTO has given the WUXILIAB trademark a serial number of 97932171. The federal status of this trademark filing is REGISTERED as of Tuesday, June 25, 2024. This trademark is owned by WUXI BIOLOGICS IRELAND LIMITED. The WUXILIAB trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research and development of antibodies; DNA screening for scientific research purposes; structural and functional analysis of genomes; Genetic screening for scientific purposes; Genetic testing for scientific research; pharmaceutical drug development services; pharmaceutical research; pharmaceutical research and development; pharmaceutical research services; Scientific research; scientific research services and new product development in the field of monoclonal antibodies; product development for others; research and development of new products; biochemical research and analysis; biomedical research services; development of pharmaceutical preparations and medicines
wuxiliab

General Information


Serial Number97932171
Word MarkWUXILIAB
Filing DateThursday, May 11, 2023
Status700 - REGISTERED
Status DateTuesday, June 25, 2024
Registration Number7430458
Registration DateTuesday, June 25, 2024
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 12, 2023

Trademark Statements


Goods and ServicesResearch and development of antibodies; DNA screening for scientific research purposes; structural and functional analysis of genomes; Genetic screening for scientific purposes; Genetic testing for scientific research; pharmaceutical drug development services; pharmaceutical research; pharmaceutical research and development; pharmaceutical research services; Scientific research; scientific research services and new product development in the field of monoclonal antibodies; product development for others; research and development of new products; biochemical research and analysis; biomedical research services; development of pharmaceutical preparations and medicines

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, May 16, 2023
Primary Code042
First Use Anywhere DateFriday, March 31, 2023
First Use In Commerce DateFriday, March 31, 2023

Trademark Owner History


Party NameWUXI BIOLOGICS IRELAND LIMITED
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressDUNDALK, CO LOUTH A91X56F
IE

Party NameWUXI BIOLOGICS IRELAND LIMITED
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressDUNDALK, CO LOUTH A91X56F
IE

Party NameWUXI BIOLOGICS IRELAND LIMITED
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressDUNDALK, CO LOUTH A91X56F
IE

Trademark Events


Event DateEvent Description
Monday, May 15, 2023NEW APPLICATION ENTERED
Tuesday, May 16, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, October 3, 2023ASSIGNED TO EXAMINER
Thursday, October 12, 2023NON-FINAL ACTION WRITTEN
Thursday, October 12, 2023NON-FINAL ACTION E-MAILED
Thursday, October 12, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, November 7, 2023EXAMINERS AMENDMENT -WRITTEN
Tuesday, November 7, 2023EXAMINERS AMENDMENT E-MAILED
Tuesday, November 7, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, November 7, 2023EXAMINER'S AMENDMENT ENTERED
Tuesday, November 7, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 22, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 12, 2023PUBLISHED FOR OPPOSITION
Tuesday, December 12, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 6, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, February 22, 2024TEAS STATEMENT OF USE RECEIVED
Thursday, February 22, 2024USE AMENDMENT FILED
Sunday, March 17, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Sunday, March 17, 2024STATEMENT OF USE PROCESSING COMPLETE
Wednesday, May 22, 2024ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, June 25, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, June 25, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Wednesday, May 22, 2024NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED